A Rare Case of Severe Metabolic Alkalosis with Unusual Hyperproteinemia Treated with Continuous Renal Replacement Therapy and Regional Citrate Anticoagulation
Status PubMed-not-MEDLINE Jazyk angličtina Země Švýcarsko Médium electronic-ecollection
Typ dokumentu kazuistiky, časopisecké články
PubMed
30197902
PubMed Central
PMC6120368
DOI
10.1159/000491628
PII: cnd-0008-0138
Knihovny.cz E-zdroje
- Klíčová slova
- Citrate accumulation, Continuous renal replacement therapy, Hyperproteinaemia, Metabolic alkalosis, Regional citrate anticoagulation, Stewart-Fencl acid base concept,
- Publikační typ
- časopisecké články MeSH
- kazuistiky MeSH
A 23-year-old woman was referred to the tertiary centre with acute kidney injury and severe metabolic alkalosis following an accidental ethylene glycol poisoning. The patient had been treated with continuous haemodiafiltration and regional citrate anticoagulation, and a tracheostomy was performed due to pneumonia. Besides severe metabolic alkalosis and hypernatremia, the laboratory tests revealed total protein of 108 g/L on admission to the tertiary centre. The haemodiafiltration with regional citrate anticoagulation continued with parallel correction of the alkalosis and normalisation of the total plasma protein. The tracheostomy was decannulated and the patient was discharged to the district hospital. The case demonstrates the usefulness of regional citrate anticoagulation even in severe metabolic alkalosis which was likely related to the method setting prior to admission and to an overcompensation of the initial severe metabolic acidosis. The unusual hyperproteinaemia might be interpreted with the aid of the Stewart-Fencl model of the acid-base regulation.
Zobrazit více v PubMed
Link A, Klingele M, Speer T, Rbah R, Pöss J, Lerner-Gräber A, et al. Total-to-ionized calcium ratio predicts mortality in continuous renal replacement therapy with citrate anticoagulation in critically ill patients. Crit Care. 2012 May;16((3)):R97. PubMed PMC
Balik M, Zakharchenko M, Leden P, Otahal M, Rulisek J, Brodska H, et al. The effects of a novel calcium-free lactate buffered dialysis and substitution fluid for regional citrate anticoagulation—prospective feasibility study. Blood Purif. 2014;38((3–4)):263–72. PubMed
Balik M, Zakharchenko M, Leden P, Otahal M, Hruby J, Polak F, et al. Bioenergetic gain of citrate anticoagulated continuous hemodiafiltration—a comparison between 2 citrate modalities and unfractionated heparin. J Crit Care. 2013 Feb;28((1)):87–95. PubMed
Balik M, Zakharchenko M, Otahal M, Hruby J, Polak F, Rusinova K, et al. Quantification of systemic delivery of substrates for intermediate metabolism during citrate anticoagulation of continuous renal replacement therapy. Blood Purif. 2012;33((1–3)):80–7. PubMed
Morgera S, Schneider M, Slowinski T, Vargas-Hein O, Zuckermann-Becker H, Peters H, et al. A safe citrate anticoagulation protocol with variable treatment efficacy and excellent control of the acid-base status. Crit Care Med. 2009 Jun;37((6)):2018–24. PubMed
Fijen JW, Kemperman H, Ververs FF, Meulenbelt J. False hyperlactatemia in ethylene glycol poisoning. Intensive Care Med. 2006 Apr;32((4)):626–7. PubMed
Oudemans-van Straaten HM, Ostermann M. Bench-to-bedside review: citrate for continuous renal replacement therapy, from science to practice. Crit Care. 2012 Dec;16((6)):249. PubMed PMC
Schneider AG, Journois D, Rimmelé T. Complications of regional citrate anticoagulation: accumulation or overload? Crit Care. 2017 Nov;21((1)):281. PubMed PMC
Katzmann JA, Clark RJ, Abraham RS, Bryant S, Lymp JF, Bradwell AR, et al. Serum reference intervals and diagnostic ranges for free kappa and free lambda immunoglobulin light chains: relative sensitivity for detection of monoclonal light chains. Clin Chem. 2002 Sep;48((9)):1437–44. PubMed
Fencl V, Jabor A, Kazda A, Figge J. Diagnosis of metabolic acid-base disturbances in critically ill patients. Am J Respir Crit Care Med. 2000 Dec;162((6)):2246–51. PubMed
Kellum JA, Elbers PW, editors. London: Lulu Enterprises, UK Ltd.; (2009). Stewart's Textbook of Acid-Base (p. 236)
Yessayan L, Yee J, Frinak S, Kwon D, Szamosfalvi B. Treatment of Severe Metabolic Alkalosis with Continuous Renal Replacement Therapy: Bicarbonate Kinetic Equations of Clinical Value. ASAIO J. 2015 Jul-Aug;61((4)):e20–5. PubMed
Hsu SC, Wang MC, Liu HL, Tsai MC, Huang JJ. Extreme metabolic alkalosis treated with normal bicarbonate hemodialysis. Am J Kidney Dis. 2001 Apr;37((4)):E31. PubMed
Wu MY, Hsu YH, Bai CH, Lin YF, Wu CH, Tam KW. Regional citrate versus heparin anticoagulation for continuous renal replacement therapy: a meta-analysis of randomized controlled trials. Am J Kidney Dis. 2012 Jun;59((6)):810–8. PubMed
Global KDI Group OKAKIW Kdigo clinical practice guideline for acute kidney injury. Kidney inter. 2012;2:1–138.